Up‐regulation of P‐glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
A major concern regarding the chronic administration of antiretroviral drugs is the potential for induction of drug efflux transporter expression (i.e., P‐glycoprotein, P‐gp) at tissue sites that can significantly affect drug distribution and treatment efficacy. Previous data have shown that the inductive effect of human immunodeficiency virus protease inhibitors (PIs) is mediated through the human orphan nuclear receptor, steroid xenobiotic receptor (SXR or hPXR). The objectives of this study were to investigate transport and inductive properties on efflux drug transporters of two PIs, atazanavir and ritonavir, at the blood–brain barrier by using a human brain microvessel endothelial cell line, hCMEC/D3. Transport properties of PIs by the drug efflux transporters P‐gp and multidrug resistance protein 1 (MRP1) were assessed by measuring the cellular uptake of 3 H‐atazanavir or 3 H‐ritonavir in P‐gp and MRP1 overexpressing cells as well as hCMEC/D3. Whereas the P‐gp inhibitor, PSC833, increased atazanavir and ritonavir accumulation in hCMEC/D3 cells by 2‐fold, the MRP inhibitor MK571 had no effect. P‐gp, MRP1, and hPXR expression and localization were examined by Western blot analysis and immunogold cytochemistry at the electron microscope level. Treatment of hCMEC/D3 cells for 72 hr with rifampin or SR12813 (two well‐established hPXR ligands) or PIs (atazanavir or ritonavir) resulted in an increase in P‐gp expression by 1.8‐, 6‐, and 2‐fold, respectively, with no effect observed for MRP1 expression. In hCMEC/D3 cells, cellular accumulation of these PIs appears to be primarily limited by P‐gp efflux activity. Long‐term exposure of atazanavir or ritonavir to brain microvessel endothelium may result in further limitations in brain drug permeability as a result of the up‐regulation of P‐gp expression and function. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid colorimetric assay for cell growth and survival
Denizot, F., & Lang, R. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90368-6 · Cited by 4,935
MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer
Leonessa, F., Green, D., Licht, T., Wright, A., Wingate-Legette, K., Lippman, J., Gottesman, M., & Clarke, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.29 · Cited by 102 · cited 1×
“P-gp substrate properties were assessed by comparing the cellular accumulation of atazanavir or ritonavir in a P-gp overexpressing human breast cancer cell line; MDA435/ LCC6-MDR1 with the parent MDA435/LCC6-WT cells (Leonessa et al., 1996).”
Background
Cited by
Nau, R., Sörgel, F., & Eiffert, H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00007-10 · Cited by 1,026
The hCMEC/D3 cell line as a model of the human blood brain barrier
Weksler, B., Romero, I. A., & Couraud, P.-O. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-16 · Cited by 753
“Abbreviations ABC-transporters: ATP-binding cassette transporters; AJ: Adherens Junction; BBB: Blood–brain barrier; BCRP: Breast cancer resistance protein; CYP: Cytochrome P-450; CECs: Cerebral endothelial cells; CNS: Central nervous system; LiCl: Lithium chloride; LY: Lucifer yellow; MDR-1: Multidrug resistance prote…”
InfluentialSelf-citationNanotechnological advances for the delivery of cns therapeutics.
Wong, H. L., Wu, X. Y., & Bendayan, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.007 · Cited by 488
Self-citationShawahna, R., Uchida, Y., Declèves, X., Ohtsuki, S., Yousif, S., Dauchy, S., Jacob, A., Chassoux, F., Daumas-Duport, C., Couraud, P.-O., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200129p · Cited by 372
Self-citationMultifunctional nanoparticles for brain tumor imaging and therapy
Cheng, Y., Morshed, R. A., Auffinger, B., Tobias, A. L., & Lesniak, M. S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.006 · Cited by 349
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Silva, R., Vilas-Boas, V., Carmo, H., Dinis-Oliveira, R. J., Carvalho, F., de Lourdes Bastos, M., & Remião, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.013 · Cited by 339
Takeshita, Y., & Ransohoff, R. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01127.x · Cited by 325
In vitro models of the blood-brain barrier
Wilhelm, I., Fazakas, C., & Krizbai, I. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1828 · Cited by 298
Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders
Qosa, H., Miller, D. S., Pasinelli, P., & Trotti, D. (2015) · Brain Research · doi:10.1016/j.brainres.2015.07.005 · Cited by 249
“Two HIV protease inhibitors, atazanavir and ritonavir, activate CAR and PXR nuclear translocation in human endothelial cells (hCMEC/D3) and in primary culture of human brain endothelial cells which in turn enhances P-gp expression (Chan et al., 2013; Zastre et al., 2009).”
BackgroundGenovese, I., Ilari, A., Assaraf, Y. G., Fazi, F., & Colotti, G. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.10.003 · Cited by 156
Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders
Gil-Martins, E., Barbosa, D. J., Silva, V., Remião, F., & Silva, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107554 · Cited by 152
Vu, K., Weksler, B., Romero, I., Couraud, P.-O., & Gelli, A. (2009) · Eukaryotic Cell · doi:10.1128/ec.00240-09 · Cited by 124
Self-citation
Metadata
- Authors
- Zastre, J. A., Chan, G. N. Y., Ronaldson, P. T., Ramaswamy, M., Couraud, P. O., Romero, I. A., Weksler, B., Bendayan, M., & Bendayan, R.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2008-10-14
- Volume
- 87
- Issue
- 4
- Pages
- 1023-1036
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2020358268
- Cited by
- 108
- References
- 2
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.